文献速递神经MR

酰胺质子转移加权成像及其衍生影像组学在成人型弥漫性胶质瘤分类中的应用

Amide proton transfer-weighted imaging and derived radiomics in the classification of adult-type diffuse gliomas.
PubMed 文献 · Eur Radiol · 2023-10-19

这项前瞻性研究对129例成人型弥漫性胶质瘤患者行APTw成像,提取CESTR、CESTRnr、MTRRex及影像组学特征,发现胶质母细胞瘤上述指标显著高于少突胶质细胞瘤和星形细胞瘤,IDH野生型及高级别胶质瘤显著高于IDH突变型及低级别胶质瘤(CESTR的AUC为0.88),CESTR影像组学模型预测IDH突变、鉴别胶质母细胞瘤与星形细胞瘤、鉴别胶质母细胞瘤与少突胶质细胞瘤及判断高/低级别的准确率分别为84%、83%、90%、84%。

要点

  • 胶质母细胞瘤的CESTR、CESTRnr、MTRRex均显著高于少突胶质细胞瘤和星形细胞瘤(p<0.0003),后两者间无显著差异。
  • IDH野生型及高级别胶质瘤的APTw相关指标显著高于IDH突变型及低级别胶质瘤(p<0.001),CESTR的AUC为0.88。
  • CESTR影像组学模型鉴别少突胶质细胞瘤与星形细胞瘤表现不佳(准确率63%,AUC 0.63)。

核心结论

  • APTw成像及其衍生影像组学是预测IDH突变和成人型弥漫性胶质瘤分级的有前景的定量方法。

研究设计与样本

  • 前瞻性研究,纳入129例成人型弥漫性胶质瘤患者,行APTw成像,提取3D肿瘤掩膜内的平均APTw相关指标(CESTR、CESTRnr、MTRRex)及影像组学特征,采用支持向量机(SVM)分类器构建APTw影像组学模型,并进行肿瘤感兴趣区、不同直方图截断值及其他分类器的敏感性分析。

关键影像表现/征象

  • 胶质母细胞瘤的CESTR、CESTRnr、MTRRex均显著高于少突胶质细胞瘤和星形细胞瘤(p<0.0003),少突胶质细胞瘤与星形细胞瘤之间无显著差异。
  • IDH野生型及高级别胶质瘤的APTw相关指标显著高于IDH突变型及低级别胶质瘤(p<0.001)。

诊断标准与关键数值

  • CESTR区分IDH野生型与IDH突变型及高级别与低级别胶质瘤的AUC为0.88。
  • CESTR影像组学模型预测IDH突变状态的准确率为84%(AUC 0.87)。
  • CESTR影像组学模型鉴别胶质母细胞瘤与星形细胞瘤的准确率为83%(AUC 0.83)。
  • CESTR影像组学模型鉴别胶质母细胞瘤与少突胶质细胞瘤的准确率为90%(AUC 0.95)。
  • CESTR影像组学模型判断高/低级别的准确率为84%(AUC 0.86);鉴别少突胶质细胞瘤与星形细胞瘤的准确率为63%(AUC 0.63)。

临床应用与阅片要点

  • APTw成像及其衍生影像组学可能作为无创诊断工具用于常规临床成人型弥漫性胶质瘤的IDH突变预测和分级。
  • CESTRnr和MTRRex可有效预测IDH突变/分级,其中CESTRnr尤为突出。
  • CESTR影像组学模型在鉴别少突胶质细胞瘤与星形细胞瘤方面表现不佳(准确率63%,AUC 0.63)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the utility of amide proton transfer-weighted (APTw) MRI imaging and its derived radiomics in classifying adult-type diffuse glioma.

MATERIALS AND METHODS: In this prospective study, APTw imaging was performed on 129 patients with adult-type diffuse gliomas. The mean APTw-related metrics (chemical exchange saturation transfer ratio (CESTR), CESTR normalized with the reference value (CESTRnr), and relaxation-compensated inverse magnetization transfer ratio (MTRRex)) and radiomic features within 3D tumor masks were extracted. APTw-radiomics models were developed using a support vector machine (SVM) classifier. Sensitivity analysis with tumor area of interest, different histogram cutoff values, and other classifiers were conducted.

RESULTS: CESTR, CESTRnr, and MTRRex in glioblastomas were all significantly higher (p < 0.0003) than those of oligodendrogliomas and astrocytomas, with no significant difference between oligodendrogliomas and astrocytomas. The APTw-related metrics for IDH-wildtype and high-grade gliomas were significantly higher (p < 0.001) than those for the IDH-mutant and low-grade gliomas, with area under the curve (AUCs) of 0.88 for CESTR. The CESTR-radiomics models demonstrated accuracies of 84% (AUC 0.87), 83% (AUC 0.83), 90% (AUC 0.95), and 84% (AUC 0.86) in predicting the IDH mutation status, differentiating glioblastomas from astrocytomas, distinguishing glioblastomas from oligodendrogliomas, and determining high/low grade prediction, respectively, but showed poor performance in distinguishing oligodendrogliomas from astrocytomas (accuracy 63%, AUC 0.63). The sensitivity analysis affirmed the robustness of the APTw signal and APTw-derived radiomics prediction models.

CONCLUSION: APTw imaging, along with its derived radiomics, presents a promising quantitative approach for prediction IDH mutation and grading adult-type diffuse glioma.

CLINICAL RELEVANCE STATEMENT: Amide proton transfer-weighted imaging, a quantitative imaging biomarker, coupled with its derived radiomics, offers a promising non-invasive approach for predicting IDH mutation status and grading adult-type diffuse gliomas, thereby informing individualized clinical diagnostics and treatment strategies.

KEY POINTS: • This study evaluates the differences of different amide proton transfer-weighted metrics across three molecular subtypes and their efficacy in classifying adult-type diffuse glioma. • Chemical exchange saturation transfer ratio normalized with the reference value and relaxation-compensated inverse magnetization transfer ratio effectively predicts IDH mutation/grading, notably the first one. • Amide proton transfer-weighted imaging and its derived radiomics holds potential to be used as a diagnostic tool in routine clinical characterizing adult-type diffuse glioma.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Wu M, Jiang T, Guo M, et al. Amide proton transfer-weighted imaging and derived radiomics in the classification of adult-type diffuse gliomas. Eur Radiol. 2023. PMID: 37855851. doi:10.1007/s00330-023-10343-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。